Updates on Amgen (NASDAQ: AMGN) ratings and price targets.
Bank of America (NYSE: BAC) raised their price target on Amgen (AMGN) to $65.00.
Citigroup (NYSE: C) raised their price target on Amgen to $73.00. They have a “Buy” rating on the company.
Piper Jaffray (NYSE: PJC) reiterated a “Neutral” rating on Amgen. They have a price target of $65.00 on the company.
TheStreet upgraded Amgen to a “Buy” rating.
UBS AG (NYSE: UBS) raised their price target on Amgen (AMGN) to $59.00. They have a “Neutral” rating on the company.
Barclays Capital (BCS) initiated coverage on Amgen. They placed an “Equal Weight” rating and a price target of $65.00 on the company.
No comments:
Post a Comment